Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,08 USD | +69,01% | +53,74% | +96,36% |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 29,73 mln. 27,57 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -76 mln. -70,47 mln. | Nettowinst (verlies) 2024 * | -68 mln. -63,05 mln. | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | 67,66 mln. 62,73 mln. | Nettoliquiditeiten 2024 * | 210 mln. 195 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,39
x | K/w-verhouding 2024 * |
-0,57
x | Werknemers | 81 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 88,47% |
Recentste transcriptie over Xilio Therapeutics, Inc.
1 dag | +69,01% | ||
1 week | +53,74% | ||
Lopende maand | +52,33% | ||
1 maand | +63,64% | ||
3 maanden | +89,47% | ||
6 maanden | -50,00% | ||
Lopend jaar | +96,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22-05-19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23-07-20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01-12-20 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 15-09-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,08 | +69,01% | 34 539 272 |
27-03-24 | 0,639 | -3,08% | 174 155 |
26-03-24 | 0,6593 | -5,80% | 81 052 |
25-03-24 | 0,6999 | -1,07% | 48 618 |
22-03-24 | 0,7075 | +0,71% | 114 472 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+96,36% | 29,73 mln. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
+4,47% | 10,81 mld. |